Larson Pharma Profile
Key Indicators
- Authorised Capital ₹ 6.50 Cr
as on 13-12-2024
- Paid Up Capital ₹ 6.45 Cr
as on 13-12-2024
- Company Age 18 Year, 8 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 10.84 Cr
as on 13-12-2024
- Satisfied Charges ₹ 5.70 Cr
as on 13-12-2024
- Revenue 96.65%
(FY 2022)
- Profit 877.75%
(FY 2022)
- Ebitda 372.35%
(FY 2022)
- Net Worth 731.95%
(FY 2022)
- Total Assets 47.56%
(FY 2022)
About Larson Pharma
The Corporate was formerly known as Larson Pharma Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 6.50 Cr and a paid-up capital of Rs 6.45 Cr.
The company currently has active open charges totaling ₹10.84 Cr. The company has closed loans amounting to ₹5.70 Cr, as per Ministry of Corporate Affairs (MCA) records.
Yeturu Reddy and Yeturu Mahalakshmi serve as directors at the Company.
- CIN/LLPIN
U24233TG2006PTC049977
- Company No.
049977
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Apr 2006
- Date of AGM
28 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Larson Pharma Private Limited offer?
Larson Pharma Private Limited offers a wide range of products and services, including Anti Infective API, Niclosamide Powder, Pharma Ingredients & Raw Materials.
Who are the key members and board of directors at Larson Pharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Yeturu Reddy  | Director | 20-Apr-2006 | Current |
| Yeturu Mahalakshmi | Director | 20-Dec-2011 | Current |
Financial Performance of Larson Pharma.
Larson Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 96.65% increase. The company also saw a substantial improvement in profitability, with a 877.75% increase in profit. The company's net worth Soared by an impressive increase of 731.95%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Larson Pharma?
In 2022, Larson Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ysr Pharma Private LimitedActive 4 years 6 monthsYeturu Reddy and Yeturu Mahalakshmi are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 30 Mar 2024 | ₹1.71 Cr | Open |
Hdfc Bank Limited Creation Date: 01 Jul 2022 | ₹1.46 M | Open |
Axis Bank Limited Creation Date: 12 May 2022 | ₹8.85 Cr | Open |
How Many Employees Work at Larson Pharma?
Larson Pharma has a workforce of 28 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Larson Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Larson Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
